PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY

被引:0
|
作者
Kockaya, G. [1 ]
Ergin, Oguzhan G. [2 ]
Kurnaz, M. [3 ]
Okcun, S. [3 ]
Talay, D. [4 ]
Gedik, Sar C. [4 ]
Saylan, M. [4 ]
机构
[1] ECONiX, Ankara, Turkey
[2] 19 Mayis Univ, Samsun, Turkey
[3] ECONiX, Istanbul, Turkey
[4] Hlth Econ & Policy Assoc, Ankara, Turkey
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRO75
引用
下载
收藏
页码:S854 / S855
页数:2
相关论文
共 50 条
  • [1] Analysis of patient access to orphan drugs in Turkey
    Güvenç Koçkaya
    Sibel Atalay
    Gülpembe Oğuzhan
    Mustafa Kurnaz
    Selin Ökçün
    Çiğdem Sar Gedik
    Mete Şaylan
    Nazlı Şencan
    Orphanet Journal of Rare Diseases, 16
  • [2] Analysis of patient access to orphan drugs in Turkey
    Kockaya, Guvenc
    Atalay, Sibel
    Oguzhan, Gulpembe
    Kurnaz, Mustafa
    Okcun, Selin
    Sar Gedik, Cigdem
    Saylan, Mete
    Sencan, Nazli
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [3] PATIENT ACCESS TO PERSONALIZED ONCOLOGY MEDICINES IN TURKEY
    Ergin, Oguzhan G.
    Kockaya, G.
    Okcun, S.
    Kurnaz, M.
    Gedik, Sar C.
    Saylan, M.
    VALUE IN HEALTH, 2019, 22 : S494 - S494
  • [4] LICENCED ORPHAN MEDICINES EXPENDITURE IN TURKEY
    Nacar, S.
    Atikeler, K.
    Beyan, A.
    Yilmaz, Safak E.
    Bayar, B.
    Vural, I. M.
    VALUE IN HEALTH, 2018, 21 : S178 - S178
  • [5] TIME TO ACCESS ORPHAN MEDICINES IN GREECE
    Chantzaras, A.
    Margetis, A.
    Kani, C.
    Koutsiouris, V
    Bacopoulou, F.
    VALUE IN HEALTH, 2023, 26 (12) : S352 - S352
  • [6] Analysis of the evolution in the access to orphan medicines in Spain
    Mestre-Ferrandiz, Jorge
    Iniesta, Margarita
    Trapero-Bertran, Marta
    Espin, Jaime
    Brosa, Max
    GACETA SANITARIA, 2020, 34 (02) : 141 - 149
  • [7] COST OF UNLICENCED AND ORPHAN MEDICINES IN TURKEY, KAZAKHSTAN AND POLAND
    Atikeler, K.
    Goettsch, W.
    Baran, A.
    Gaitova, K.
    Bayar, B.
    Czech, M.
    Leufkens, H. G.
    VALUE IN HEALTH, 2018, 21 : S168 - S168
  • [8] Patient access to orphan drugs
    Cohen, Joshua P.
    Awatin, Josephine G.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (12): : 923 - 932
  • [9] Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
    Merlini, Giampaolo
    Gribben, John
    Macintyre, Elizabeth
    Piggin, Maria
    Doeswijk, Robin
    HEMASPHERE, 2020, 4 (05):
  • [10] INTERNATIONAL COOPERATION AS A PREREQUISITE FOR IMPROVEMENT OF ACCESS TO ORPHAN BIOLOGIC MEDICINES
    Wieckowski, Zbigniew
    MEDICINE LAW & SOCIETY, 2021, 14 (02): : 479 - 493